DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended September 30, 2014.
Product revenue grew to $67.9 million for the third quarter of 2014, an increase of 60% from the $42.5 million in product revenue reported for the third quarter of 2013. Total revenue, which included development grant and other revenue, grew to $69.0 million for the third quarter of 2014, an increase of 61% from the same quarter in 2013.
Help employers find you! Check out all the jobs and post your resume.
